Clinical Trial Update: A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

View source ↗

Summary

This clinical trial update notes that the quarterly intravenous ibandronate (Bonviva) study in women with postmenopausal osteoporosis is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Bonviva (ibandronic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Postmenopausal Osteoporosis | Status: NO_LONGER_AVAILABLE